dc.creatorMartins L.
dc.creatorLeoni S.G.
dc.creatorFriguglietti C.U.M.
dc.creatorWard L.S.
dc.creatorKulcsar M.A.V.
dc.creatorKimura E.T.
dc.date2006
dc.date2015-06-30T18:07:27Z
dc.date2015-11-26T14:24:00Z
dc.date2015-06-30T18:07:27Z
dc.date2015-11-26T14:24:00Z
dc.date.accessioned2018-03-28T21:26:05Z
dc.date.available2018-03-28T21:26:05Z
dc.identifier
dc.identifierArquivos Brasileiros De Endocrinologia E Metabologia. , v. 50, n. 6, p. 1075 - 1081, 2006.
dc.identifier42730
dc.identifier10.1590/S0004-27302006000600014
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-33846445703&partnerID=40&md5=d637f3ef2b517234c21e7260df9cd33a
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/103165
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/103165
dc.identifier2-s2.0-33846445703
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1245277
dc.descriptionGalectin-3 is a multifunctional protein highly expressed in thyroid cancer. The galectin-3 gene (LGALS3) has several annotated candidates SNPs, however the relationship between galectin-3 SNPs and specific phenotypic variations relevant to health has not been evaluated. In this study, we investigated SNPs in the galectin-3 gene and a putative association with thyroid tumorigenesis. The presence of LGALS3 SNPs in thyroid carcinoma cell lines (NPA, TPC-1, WRO, ARO), thyroid tissues of 55 patients with multinodular goiter or papillary carcinoma diagnosis and lymphocytes of peripherical blood of 45 healthy individuals was evaluated by sequencing and SSCP. The analysis of LGALS3 coding sequence showed that the T98P site presents a great genotypic variation, since we observed both homozygous (AA or CC) and heterozygous (AC) patterns. In thyroid carcinoma cell lines, the genotype of NPA in the LGALS3 T98P site is CC, while TPC-1, WRO and ARO are AC. The genotypic frequency of T98P SNP observed in multinodular goiter (AC= 67%; AA= 23%; CC= 10%) and papillary carcinoma (AC= 68%; AA= 20%; CC= 12%) were similar to the frequency observed in the control population (AC= 60%, AA= 24%, CC=16%). In conclusion, no association between LGALS3 T98P genotype and the phenotype of the benign or malignant thyroid tumor was observed.
dc.description50
dc.description6
dc.description1075
dc.description1081
dc.descriptionLiu, F.T., Patterson, R.J., Wang, J.L., Intracellular functions of galectins (2002) Biochim Biophys Acta, 1572 (2-3), pp. 263-273
dc.descriptionYoshii, T., Inohara, H., Takenaka, Y., Honjo, Y., Akahani, S., Nomura, T., Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells (2001) Int J Oncol, 18 (4), pp. 787-792
dc.descriptionXu, X.C., el-Naggar, A.K., Lotan, R., Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications (1995) Am J Pathol, 147 (3), pp. 815-822
dc.descriptionInohara, H., Honjo, Y., Yoshii, T., Akahani, S., Yoshida, J., Hattori, K., Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms (1999) Cancer, 85 (11), pp. 2475-2484
dc.descriptionBartolazzi, A., Gasbarri, A., Papotti, M., Bussolati, G., Lucante, T., Khan, A., Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions (2001) Lancet, 357 (9269), pp. 1644-1650
dc.descriptionNascimento, M.C.P.A., Bisi, H., Alves, V.A.F., Longatto-Filho, A., Kanamura, C.T., Medeiros-Neto, G., Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas (2001) Endocr Pathol, 2, pp. 275-279
dc.descriptionSaggiorato, E., Aversa, S., Deandreis, D., Arecco, F., Mussa, A., Puligheddu, B., Galectin-3: Presurgical marker of thyroid follicular epithelial cell-derived carcinomas (2004) J Endocrinol Invest, 27 (4), pp. 311-317
dc.descriptionMartins, L., Matsuo, S.E., Ebina, K.N., Kulcsar, M.A., Friguglietti, C.U., Kimura, E.T., Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors (2002) J Clin Endocrinol Metab, 87 (10), pp. 4806-4810
dc.descriptionErichsen, H.C., Chanock, S.J., SNPs in cancer research and treatment (2004) Br J Cancer, 90 (4), pp. 747-751
dc.descriptionKaklamani, V.G., Hou, N., Bian, Y., Reich, J., Offit, K., Michel, L.S., TGFBR1*6A and cancer risk: A meta-analysis of seven case-control studies (2003) J Clin Oncol, 21 (17), pp. 3236-3243
dc.descriptionStephens, L.A., Powell, N.G., Grubb, J., Jeremiah, S.J., Bethel, J.A., Demidchik, E.P., Investigation of loss of heterozygosity and SNP frequencies in the RET gene in papillary thyroid carcinoma (2005) Thyroid, 15 (2), pp. 100-104
dc.descriptionBaumgartner-Parzer, S.M., Lang, R., Wagner, L., Heinze, G., Niederle, B., Kaserer, K., Polymorphisms in exon 13 and intron 14 of the RET protooncogene: Genetic modifiers of medullary thyroid carcinoma? (2005) J Clin Endocrinol Metab, 90 (11), pp. 6232-6236
dc.descriptionGranja, F., Morari, J., Morari, E.C., Correa, L.A.C., Assumpção, L.V.M., Ward, L.S., Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer (2004) Cancer Lett, 210, pp. 151-157
dc.descriptionBasolo, F., Giannini, R., Faviana, P., Fontanini, G., Patricelli Malizia, A., Ugolini, C., Thyroid papillary carcinoma: Preliminary evidence for a germ-line single nucleotide polymorphism in the Fas gene (2004) J Endocrinol, 182, pp. 479-484
dc.descriptionMatakidou, A., Hamel, N., Popat, S., Henderson, K., Kantemiroff, T., Harmer, C., Risk of non-medullary thyroid cancer influenced by polymorphic variation in the thyroglobulin gene (2004) Carcinogenesis, 25 (3), pp. 369-373
dc.descriptionCooper, D.N., Galectinomics: Finding themes in complexity (2002) Biochim Biophys Acta, 1572 (2-3), pp. 209-231
dc.descriptionAltschul, S.F., Madden, T.L., Schaffer, A.A., Zhang, J., Zhang, Z., Miller, W., Gapped BLAST and PSI-BLAST: A new generation of protein database search programs (1997) Nucleic Acids Res, 25 (17), pp. 3389-3402
dc.descriptionThompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. <B>Nucleic Acids Res 1997</B>25:4876-82Guttmacher, A.E., Collins, F.S., Drazen, J.M., (2004) Genomic medicine: Articles from the New England Journal of Medicine, , Baltimore: The Johns Hopkins University Press
dc.descriptionGong, H.C., Honjo, Y., Nangia-Makker, P., Hogan, V., Mazurak, N., Bresalier, R.S., The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells (1999) Cancer Res, 59 (24), pp. 6239-6245
dc.languagept
dc.publisher
dc.relationArquivos Brasileiros de Endocrinologia e Metabologia
dc.rightsaberto
dc.sourceScopus
dc.titlePolymorphism On Codon 98 Of The Galectin-3 Gene Are Not Associated To Benign And Malignant Thyroid Tumors [o Polimorfismo No Códon 98 Do Gene De Galectina-3 Não Está Associado A Tumores Benignos E Malignos De Tiróide]
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución